Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

E. Chabrière

New Microbes and New Infections (Jan 2021)

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

E. Chabrière

Affiliations

E. Chabrière: Corresponding author: E. Chabrière, Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.; Aix-Marseille Université, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France

Journal volume & issue: Vol. 39
p. 100711

Abstract

Read online

During COVID-19 pandemic the Gilead Sciences stock prices rose sharply with large variations. These fluctuations have been tentatively related to communications, publications or leaks about remdesivir or hydroxychloroquine/azithromycin treatment.

Published in New Microbes and New Infections

ISSN: 2052-2975 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://www.sciencedirect.com/journal/new-microbes-and-new-infections

About the journal

Abstract

Keywords